These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22466824)

  • 1. Prognostic factors in malignant pleural mesothelioma: a retrospective study.
    Suzuki H; Hirashima T; Kobayashi M; Okamoto N; Matsuura Y; Tamiya M; Morishita N; Okafuji K; Shiroyama T; Morimura O; Morita S; Kawase I
    Intern Med; 2012; 51(7):707-10. PubMed ID: 22466824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratification of malignant pleural mesothelioma prognosis using recursive partitioning analysis.
    Suzuki H; Asami K; Hirashima T; Okamoto N; Yamadori T; Tamiya M; Morishita N; Shiroyama T; Takeoka S; Osa A; Azuma Y; Okishio K; Kawaguchi T; Atagi S; Kawase I
    Lung; 2014 Feb; 192(1):191-5. PubMed ID: 24141556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.
    Fennell DA; Parmar A; Shamash J; Evans MT; Sheaff MT; Sylvester R; Dhaliwal K; Gower N; Steele J; Rudd R
    J Clin Oncol; 2005 Jan; 23(1):184-9. PubMed ID: 15625372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.
    Billé A; Krug LM; Woo KM; Rusch VW; Zauderer MG
    J Thorac Oncol; 2016 Feb; 11(2):249-55. PubMed ID: 26845118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and survival in malignant pleural mesothelioma.
    Van Gelder T; Damhuis RA; Hoogsteden HC
    Eur Respir J; 1994 Jun; 7(6):1035-8. PubMed ID: 7925870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma.
    Berardi R; Fiordoliva I; De Lisa M; Ballatore Z; Caramanti M; Morgese F; Savini A; Rinaldi S; Torniai M; Tiberi M; Ferrini C; Onofri A; Cascinu S
    Tumori; 2016; 102(2):190-5. PubMed ID: 26893272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.
    Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S
    Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.
    Nojiri S; Gemba K; Aoe K; Kato K; Yamaguchi T; Sato T; Kubota K; Kishimoto T
    Jpn J Clin Oncol; 2011 Jan; 41(1):32-9. PubMed ID: 20798232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors according to the treatment schedule in malignant pleural mesothelioma.
    Ak G; Metintas S; Metintas M; Yildirim H; Erginel S; Kurt E; Alatas F; Cadirci O
    J Thorac Oncol; 2009 Nov; 4(11):1425-30. PubMed ID: 19752758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
    Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
    J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors affecting survival in malignant pleural mesothelioma: analysis of 125 subjects.
    Komurcuoglu B; Cirak AK; Kirakli SC; Polat G; Yucel N; Usluer O; Erer O; Balci G; Gayaf M; Guldaval F; Aktogu S; Guclu S; Ozsoz A; Halilcolar H
    Tumori; 2014; 100(1):55-9. PubMed ID: 24675492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.
    Cedrés S; Montero MA; Zamora E; Martínez A; Martínez P; Fariñas L; Navarro A; Torrejon D; Gabaldon A; Ramon Y Cajal S; Felip E
    Clin Transl Oncol; 2014 Sep; 16(9):776-82. PubMed ID: 24323466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor Prognostic Factors in Patients with Malignant Pleural Mesothelioma Classified as Pathological Stage IB According to the Eighth Edition TNM Classification.
    Takuwa T; Hashimoto M; Kuroda A; Nakamura A; Nakamichi T; Fukuda A; Matsumoto S; Kondo N; Hasegawa S
    Ann Surg Oncol; 2018 Jun; 25(6):1572-1579. PubMed ID: 29616420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM).
    Cedrés S; Montero MA; Martinez P; Martinez A; Rodríguez-Freixinós V; Torrejon D; Gabaldon A; Salcedo M; Ramon Y Cajal S; Felip E
    Lung Cancer; 2012 Jul; 77(1):192-8. PubMed ID: 22459204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for 100 patients with malignant pleural mesothelioma.
    Gonlugur U; Gonlugur TE
    Arch Environ Occup Health; 2010; 65(2):65-9. PubMed ID: 20439224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-pathological prognostic factors in malignant pleural mesothelioma].
    Nakano K; Shiota Y; Ono T; Taniyama K; Hiramoto T; Yamakido M
    Nihon Kokyuki Gakkai Zasshi; 2007 Feb; 45(2):153-9. PubMed ID: 17352172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma.
    Abakay A; Komek H; Abakay O; Palanci Y; Ekici F; Tekbas G; Tanrikulu AC
    Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1233-41. PubMed ID: 23690193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and therapeutic strategy in malignant pleural mesothelioma.
    Branscheid D; Krysa S; Bauer E; Bülzebruck H; Schirren J
    Eur J Cardiothorac Surg; 1991; 5(9):466-72; discussion 473. PubMed ID: 1931091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.